Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Geburtshilfe Und Frauenheilkunde|January 18, 2019
Joint Guideline of the OEGGG, AGO, AGK and ÖGZ on the Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Appropriate Procedures When Cytological Specimens Are UnsatisfactoryOlaf Reich, Georg Braune, Wolfgang Eppel, et al.Gynecologic Oncology|February 18, 2022
Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trialStephan Polterauer, Olaf Reich, Andreas Widschwendter, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 26, 2025
Cervical Human Papillomavirus-Independent Squamous Cell Carcinoma: A Clinicopathological Review and Outcomes Analysis Compared With Human Papillomavirus-Associated Squamous Cell CarcinomaSimona Stolnicu, Natalia Rakislova, Alba Morató, et al.Gynecologic Oncology|January 23, 2026
Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV statusDeepti Jain, Marya Wahidi, Judy Effendi, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 21, 2022
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesionsMario Preti, Elmar Joura, Pedro Vieira-Baptista, et al.Journal of Lower Genital Tract Disease|June 28, 2022
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar LesionsMario Preti, Elmar Joura, Pedro Vieira-Baptista, et al.International Journal of Cancer|July 4, 2012
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in EuropeWiebren A Tjalma, Alison Fiander, Olaf Reich, et al.International Journal of Cancer|June 23, 2015
Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological studyKatsiaryna Holl, Andrzej M Nowakowski, Ned Powell, et al.Vaccine|March 7, 2021
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 studyElmar A Joura, Angels Ulied, Corinne Vandermeulen, et al.Geburtshilfe Und Frauenheilkunde|February 23, 2019
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-upPeter Hillemanns, Klaus Friese, Christian Dannecker, et al.Pageof 10